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Comparative Acute and Subchronic Toxicity
of Ethylene Glycol Monopropyl Ether and
Ethylene Glycol Monopropyl Ether Acetate
by Gary V. Katz,* Walter J. Krasavage* and C. J. Terhaar*
The acute toxicity of ethylene glycol monopropyl ether (EGPE) and ethylene glycol monopropyl ether
acetate (EGPEA) was determined in a series ofstandardized tests. The oral LD50 in rats was 3089 and 9456
mg/kg EGPE and EGPEA, respectively. Skin irritation was slight following an occluded single dose
application of either compound to the guinea pig abdomen. The dermal LD50 for guinea pigs was 1 to 5
mL/kg and greater than 20 mL/kg EGPE and EGPEA, respectively. EGPE produced a very weak positive
sensitization response in one offive guinea pigs. No positive response was elicited when 10 guinea pigs were
similarly challenged with EGPEA. EGPE produced transient moderate to severe eye irritation in rabbits
while EGPEA produced slight eye irritation. Subchronic toxicity was determined in a series of oral and
inhalation studies. Groups of 10 male rats were dosed with 15, 7.5, 3.75 or 1.88 mmole/kg EGPE and 30, 15
or 7.5 mmole/kg EGPEA by gavage 5 days/week for 6 weeks. Hemoglobinuria was seen at least once at all
dose levels of both compounds. EGPE had little effect on feed consumption or body weight gain, while
body weight gain was reduced in the two high dose groups exposed to EGPEA and feed consumption was
reduced at all dose levels. Hematologic changes were seen at all dose levels of both compounds. Absolute
and/or relative spleen weights were increased at all but the lowest EGPE dose level and at all EGPEA dose
levels. Gross and histopathologic examinations revealed significant effects on the spleen ofanimals exposed
to EGPE and on the spleen, liver, kidney and testes ofanimals exposed to EGPEA. The no-observed effect
level (NOEL) for splenic changes was 1.88 mmole/kg EGPE. A NOEL for hematology was not established.
The NOEL for liver and testicular changes were 15 and 7.5 mmole/kg EGPEA, respectively while a NOEL
for hematologic, splenic and renal changes was not established. Groups of10 rats (5M, 5F) were exposed to
800, 400, 200 or 100 ppm EGPE or EGPEA 6 hr/day, 5 days/week for a total of 11 exposures. Body weight
gains in all exposure groups were comparable to controls. Hemoglobinuria was seen only after the first or
second exposure in males and females exposed to 800 ppm EGPE and in males exposed to 400 ppm EGPE.
Males and females exposed to 800 ppm EGPEA and females exposed to 400 and 200 ppm EGPEA also
exhibited hemoglobinuria. Hematologic changes were seen in males and females exposed to 800 and 400
ppm EGPE and EGPEA. Absolute and/or relative spleen weights were increased at 800 and 400 ppm EGPE
and EGPEA. Gross and histopathologic examinations revealedsplenic effects in males and females exposed
to 800 and 400 ppm EGPE and 800 ppm EGPEA. The NOEL was 200 ppm EGPE and 100 ppm EGPEA.
Introduction
The acute and subchronic toxicity of ethylene glycol
monomethylether(EGME), ethyleneglycolmonomethyl
ether acetate (EGMEA), ethylene glycol monoethyl
ether (EGEE), and ethylene glycol monoethyl ether
acetate (EGEEA) has been studied in several animal
species. The acute toxicity of these compounds follow-
ing single-dose oral and inhalation administration is
relatively low. Reported oral LD50 values forthe rat are:
EGME, 2.46 to 3.4 g/kg (1,2); EGMEA, 3.39 to 3.93
g/kg (3,4); EGEE, 3.46 to 5.5 g/kg (1,2,5,6); and
EGEEA, 5.1 g/kg (4). Reported inhalation LC50 values
for the rat are: EGME, 2000 ppm/4 hr (7); EGMEA,
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7000 ppm/4 hr (3); EGEE, 4000 ppm/4 hr (7); and
EGEEA, 1500 ppm/8 hr (8). Skin irritation was mild
following application of all four compounds to rabbits
(1,9). All four compounds were mildly irritating to the
rabbit eye with conjunctival and corneal irritation being
transitory (1).
Repeated oral administration of the four compounds
produces testicular atrophy and leukopenia, with kidney
damage and hematuria reported for EGME, EGEE,
and EGMEA (1). The principal effects following inhala-
tion exposure to all the compounds are hematologic.
Injury to lung, liver and kidneys has also been reported
(1).
The objective of the following study was to compare
and contrast the acute and subchronic toxicity of the
next higher homologs in this series of straight chain
glycol derivatives, i.e., ethylene glycol monopropylKATZ, KRASAVAGE AND TERHAAR
ether (EGPE) and ethylene glycol monopropyl ether
acetate (EGPEA).
Methods and Materials
Test Compounds
EGPE and EGPEA were obtained from Tennessee
Eastman Company (Kingsport, TN). Physical-chemical
properties are compared in Table 1.
The purity of the EGPE and EGPEA was deter-
minedbygaschromatography andmassspectroscopyand
was found to be about 99.5 and 99.6%, respectively. The
main impurities were 2-n-butoxyethanol, triethylene
glycol n-butyl ether, and isopropyl ethanol for the
EGPE tested. EGPE, acetic acid, propyl acetate, hexyl
acetate, ethylene glycol monobutyl ether acetate and
EGEEA (50-100 ppm) were impurities identified in the
EGPEA tested.
Single-Dose Oral LD50 Studies
Groups of five male rats [COBS/CD/(SD)BR] from
Charles RiverBreedingLaboratories (Wilmington, MA)
weighing 150 to 200 g were given oral doses of 10.5,
21.0, 42.0 and 84.0 mmole/kg (EGPE and EGPEA) and
168.0 mmole/kg (EGPE only), roughly equal to 1090,
2180, 4360, 8720 or 17,470 mg/kg EGPE and 1530, 3070,
6140, or 12,280 mg/kg EGPEA. Dose administration
was by gavage, undiluted, using a glass syringe fitted
withapolypropylene catheter. Theanimalswereindivid-
ually housed in suspended wire-bottom cages. Water
and feed were available ad libitum, except the animals
that were fasted 16 to 20 hr prior to treatment. General
appearance and activity, toxicologic signs and mortality
were checked twice daily except weekends and holidays.
The appearance of stools and urine on the dropping
trays was noted and individual body weights were done
prior to dosing and at the end ofthe 2-week observation
period. The LD50 and the 95% confidence interval was
calculated by the method of Weil (10).
Single-Exposure Inhalation LC50 Studies
Groups of four male rats [COBS CD (SD)BR] from
Charles RiverBreedingLaboratories (Wilmington, MA)
weighing 150 to 200 g were exposed to target concentra-
Table 1. Physicochemical properties of EGPE and EGP'EA.
EGPE EGPEA
Synonym 2-Propoxyethanol 2-Propoxyethyl acetate
Structural formula C:jH70CHXCH,0H C,H7OCHXCH.OOCCHt
Molecular weight 104.15 146.21
Boiling point, °C 149.5 170-1
Melting point, °C < -90 < -45
Specific gravity 0.91 0.93
Vapor pressure,
mm Hg at 25°C 1.3 0.5
Flash point, °F 120 142
tions of2000, 1000, 500, 250 or 0 ppm EGPE and 1000,
500, 250 or 0 ppm EGPEA. Animals received a single
6-hrexposure in20-L glassbell-jarinhalation chambers.
The highest vapor concentration was chosen as the
most practical upper limit achievable. Vapors ofthe test
materials were produced by slight heating ofthe liquid
contained in a three-necked round-bottomed flask. The
vapors were diluted with oil-free compressed air as
necessary prior to entering the bell-jar chambers.
Concentrations were determined at least once per hour
by infrared analysis (Miran IA-Foxboro/Wilks, Inc.,
Norwalk, CT). The animals were observed formortality
and clinical signs oftoxicity daily and for mortality only
on weekends. Body weights were determined twice
weekly
Single-Dose Dermal Studies
Primary skin irritation was determined by applica-
tion of the compound to the depilated abdomen of
guinea pigs dosed with 1, 5, 10 or 20 mL/lkg EGPE or
EGPEA under an occlusive wrap for 24 hr. The com-
pound was placed on a Webril pad which was glued to a
strip ofrubber dental dam. The strip ofdental dam was
wrapped around the trunk of the guinea pig. The
anterior and posterior edges of the dam were taped to
the animal's body. Observations were made immediately
following removal ofthe wrapping (24 hr after dosing),
and 1 and 2 weeks after dosing. Body weights were
determined before dosing and 2 weeks afterdosing. The
dermal LD50 was estimated as greater than the largest
dose causing no mortality or between two doses as
appropriate.
Repeated Topical Application Studies
Groups offive guinea pigs received 0.5 mL EGPE or
EGPEA applied topically on close-clipped back skin.
The test material was applied undiluted. At 24 hr after
application, the treated area of the skin was depilated
and the skin observed forthe presence ofabnormalities.
On subsequent days, except Sunday, the treated area of
the back skin was similarly treated for a total of 10
doses. The skin was clipped again on day 7 and
depilated 24 hr after the last (10th) dose. Succeeding
observations were compared to those made 24 hr after
dosingand exacerbation was considered present ifthere
was an increase in severity in any one sign. Animals
were weighed prior to the first dose and after the last
dose.
Sensitization Studies
A group of five guinea pigs received a footpad
injection (0.05 mL) of Freund's complete adjuvant.
After 1 week, 0.3 mL of a 1% solution (acetone-base
solvent) ofthe test material was applied (drop-on) to the
depilated backs of the guinea pigs to assess irritation
potential. Subsequently, two groups ofguinea pigs (five
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each for EGPE studies and ten each for EGPEA
studies) received a footpad injection (0.05 mL) of
Freund's complete adjuvant with and without 1% ofthe
test material. One week later, a challenging dose of0.3
mL of the appropriate solution (1%) of EGPE or
EGPEA was dropped on the depilated back skin.
Observations were made 24 and 48 hr later.
Primary Eye Irritation Studies
One eye each of six rabbits was treated by dropping
0.1 mL EGPE or EGPEA into the conjunctival sac
formed by pulling the lower eyelid away from the eye.
The lids were then held together for approximately 1
sec and released. Immediately after the eyelids were
released the conjunctival sac and the surface of the
treated eye in three ofthe rabbits was copiously washed
with distilled water. The untreated eye of each rabbit
was used as a control. The eyes were observed and
evaluated promptly (within 1 min) and 1, 24, 48 hr and
14 days after treatment. Ocular lesions were graded
according to guidelines (Draize) recommended by the
U. S. Department of Health, Education, and Welfare.
Fluorescein sodium ophthalmic solution, U.S.P, was
dropped onthe cornea ofeach eye 24 hraftertreatment.
The eye and conjunctival sac were flushed with distilled
waterandthepresence orabsenceofstainingwasnoted.
Subchronic Studies
Six-Week OralStudies. Forty male rats [COBS CD
(SD)BR)] from Charles River Breeding Laboratories
(Wilmington, MA) weighing 239 + 13 g were randomly
divided into four equal groups. Doses of EGPE, 1560,
780, and 390 mg/kg (15, 7.5, and 3.75 mmole/kg) which
were approximately equivalent to 1/2, 1/4, and 1/8 the
acute oral LD50, were administered undiluted bygavage
five days per week for six weeks. Control animals
received a volume ofdistilled water equal to the largest
volume given a treated animal. All doses were recalcul-
ated weekly to adjust for body weight. Another 40 male
rats weighing 216 + 6 g were treated similarly with
4386, 2193 and 1097 mg/kg (30, 15, and 7.5 mmole/kg)
EGPEA. These doses were also approximately equiva-
lent to 1/2, 1/4 and 1/8 the acute oral LD50 of EGPEA.
An additional group of 10 rats weighing 232 + 25 g
received EGPE at a lower concentration 195 mg/kg
(1.88 mmole/kg, 1/16 the LD50) in an attempt to
establish a no-effect level. All animals were housed
individually in suspended wire cages and Purina Rodent
Chow 5001 and water, via an automatic watering
system, were available ad libitum.
Two-Week Inhalation Studies. Twenty-five male
and twenty-five female rats [COBS CD (SD)BR] from
Charles RiverBreedingLaboratories (Wilmington, MA)
weighing 212 ± 7 and 187 ± 5 g, respectively, were
randomly divided into five equal groups of each sex.
Both sexes were exposed to800, 400, 200, 100, or 0 ppm
EGPE 6 hr/day, 5 days/week for a total of 11 exposures.
Controls were treated identically to the test groups
exceptthat exposure wastofiltered aironly. All animals
were housed individually in suspended wire cages and
Purina Rodent Chow 5001 and water, via an automatic
watering system, were available ad libitum during
nonexposure intervals only.
Vapors were produced by heating (up to 40°C) the
EGPE containedinthree-neckedround-bottomedflasks.
The vapors were mixed with metered air and further
diluted as necessary prior to entering 4200 L inhalation
chambers. Chamber atmospheres were quantitatively
analyzed at least once per hour by a gas chromatograph
equipped for automated sampling and analysis. Periodic
measurements of nongaseous airborne material were
made in each chamber using a Royco five-channel
particle analyzer to insure the absence of aerosol.
Animal cage positions within each chamber were
changed daily in a sequential manner. Chambertemper-
ature and humidity were monitored at least once per
hour and were maintained at approximately 21°C and
50% relative humidity.
Another 25 male and 25 female rats weighing 212 + 8
and 183 ± 7 g, respectively, followed a similar regimen
but were exposed to 800, 400, 200, 100 and 0 ppm of
EGPEA. These animals were exposed in 420 L cham-
bers and analyses of chamber atmospheres was by a
Miran IA infrared analyzer equipped for automated
sampling and analysis.
Clinical Observations. Individual body weights
were recorded at least once weekly in the 6-week oral
and 2-week inhalation studies. Feed consumption was
recorded with body weights in the oral study. Feed
consumption was not determined in the inhalation
studies. Animals were observed twice daily for clinical
signs of toxicity in the oral studies, and prior, during,
and after exposures in the inhalation studies. Animals
were observed for mortality on weekends. Animals that
died spontaneously were autopsied promptly and mori-
bund animals were euthanized with CO2 and autopsied.
Tissues were collected for histopathologic examination.
Organ weights, clinical chemistries and hematology
were not done for animals dying spontaneously.
Hematology and Clinical Chemistry. All animals
were fasted for 16 to 20 hr prior to autopsy. At
termination, the survivors were anesthetized by CO2
inhalation (oral studies) or by IP injection of sodium
pentobarbital (inhalation studies). Blood was drawn
from the inferior vena cava just prior to autopsy.
Animals were killed by exsanguination. Hematologic
analyses (hemoglobin concentration, hematocrit, red
and white blood cell counts, platelet counts and red cell
indices) were performed usingan ELT-8 LaserHematol-
ogy Analyzer (Ortho Instruments, Westfield, MA).
Differential white cell counts were performed by
microscopy. Serum clinical chemistry determinations
were done with either a Beckman Enzyme Activity
Analyzer System TR (Beckman Instruments Inc.,
Fullerton, CA) for alanine amino-transferase, aspartate
aminotransferase, and alkaline phosphatase or with a
167KATZ, KRASAVAGE AND TERHAAR
COBAS-BIO Centrifugal Analyzer (Roche Analytical
Instruments, Nutley, NJ) for lactic dehydrogenase,
urea nitrogen, creatinine, sorbitol dehydrogenase, and
glucose.
Gross and Histopathology. The heart, liver, kid-
neys, testes, ovaries (inhalation study only), brain and
spleen were trimmed and weighed for organ/body
weight comparisons.
The following tissues were fixed in 10% buffered
formalin, embedded in paraffin, sectioned at 5 ,um,
stained with hematoxylin eosin, and examined by light
microscopy: nasal passages, trachea, lungs, thymus,
heart, tongue, esophagus, stomach, duodenum, jeju-
num, ileum, cecum, colon, liver, kidneys, urinary
bladder, pituitary gland, adrenal glands, pancreas,
thyroid glands, parathyroid glands, spleen, mesenteric
lymph nodes, bone marrow, brain, salivary glands,
testes, epididymides, accessory sex organs (males), and
ovaries, uterus, fallopian tubes and vagina. Eyes were
fixed in Zenker's solution.
Analysis of Numerical Data
Body weights, organ weights and, where applicable,
all numerical data, were analyzed by using a one-way
analysis of variance (p S 0.05) and Duncan's multiple
range test.
Results
Acute Studies
The acute toxicity of both compounds is compared in
Table 2. The oral LD50 values were 3089 mg/kg EGPE
and 9456 mg/kg EGPEA. The 95% confidence intervals
were 2090 to 4576 and 7957 to 11,239 mg/kg,
respectively. Clinical signs of toxicity were abnormal
respiratory patterns, weakness, anorexia, hemoglo-
binuria, tremors (EGPE animals only), prostration,
and death.
The 6-hr inhalation LC50 for male rats was greater
than 2132 ppm EGPE and greater than 934 ppm
EGPEA, the highest practical vapor concentrations
achievable without concomitant aerosol exposure. No
mortality was observed at any exposure concentration
tested. Body weight gains over the 14-day observation
Table 2. Comparative acute toxicity of EGPE and EGPEA.
Type of dose Species EGPE EGPEA
Oral LDI,, Rat 3089 mg/kg 9456 mg/kg
Inhalation LC;,, Rat > 2132 ppm/6hr > 934 ppm/6hr
Skin
Dermal LDx, Guinea pig 1-5 mL/kg > 20 mL/kg
Single-occluded Guinea pig Slight Slight
Repeated-open Guinea pig Slight Slight
exacerbation exacerbation
Sensitization Guinea pig Weak (1/5) None (0/10)
Eye Rabbit Transient Slight
mod.-sev.
period were normal. Clinical signs of toxicity were
hemoglobinuria at concentrations of 1121 and 2132 ppm
EGPE and 934 ppm EGPEA. No other significant
clinical signs of toxicity were observed.
Both compounds produced slight skin irritation when
applied to the depilated abdomen of guinea pigs under
an occlusive wrap for 24 hr. Erythema and edema
observed at 24 hr resolved within 1 week. Only desqua-
mation was seen 1 and 2 weeks after removal of the
wrap. All animals exposed to 5 mL/kg EGPE died,
while all animals exposed to 1 mL/kg EGPE and 20
mL/kg EGPEA survived. Thus, the dermal LD50 was
estimated to be between 1 and 5 mL/kg EGPE (about 1
to 5 g/kg) and greater than 20 mL/kg EGPEA (about 20
g/kg). Ten daily applications ofEGPE or EGPEA to the
clipped backs of guinea pigs over an 11-day period
slightly exacerbated the responses seen after the initial
application. No mortality was observed.
When tested using a standardized skin procedure, a
weak positive response was seen in one out of five
guinea pigs challenged with EGPE while no positive
responses were elicited in ten guinea pigs challenged
with EGPEA. Thus, EGPEA does not appear to be a
sensitizer while EGPE, at most, has a very low
sensitization potential.
EGPE produced a moderate to strong eye irritation
causing severe erythema and moderate edema of the
conjunctivae. Iritis, and staining of the adnexa and
cornea ofrabbit eyes was also apparent. Some degree of
corneal opacity was seen in all eyes tested. All
responses, however, resolved by 14 days. EGPEA was a
slight eye irritant causing erythema and edema of the
conjunctivae and nictitating membrane. All responses
resolved within 48 hr. Prompt irrigation had a slightly
palliative effect with both compounds.
Subchronic Studies
Six-Week Oral Studies. Mortality following admini-
stration of EGPE and EGPEA is compared in Table 3.
Spontaneous deaths, 2/10, 3/10 and 1/10, dosed with 15,
7.5 and 3.75 mmole/kg EGPE, respectively, were seen
immediately after dosing. Two ofthe three deaths at 7.5
mmole and one at 3.75 mmole/kg appeared to be due to
aspiration of the chemical into the lung. No mortality
was seen in the groups dosed with 1.88 and 0 mmole/kg
EGPE. In contrast, 6/10 rats died after two or three
Table 3. Mortality following administration of EGPE and
EGPEA: 6-week gavage study.
30
mmole/
15
mmole/
7.5
mmole/
3.75
mmole/
1.88
mmole/
kg kg kg kg kg 0
EGPE (mg/kg) _a 1560 780 390 195 0
Mortality 2/10 3/10 1/10 0/10 0/10
EGPEA (mg/kg) 4386 2193 1097 0
Mortality 10/10 0/10 0/10 0/10
aStudy not conducted at these doses.
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doses of 30 mmole/kg EGPEA. Additionally, two rats
were killed after two doses because of inanition and
anorexia and two rats died after 18 doses. No mortality
was seen in groups dosed with 15, 7.5, or 0 mmole/kg
EGPEA.
Body weight gains of all groups exposed to EGPE
were statistically similar to controls except for a slight
weight loss in the high dose group on day3 only (Fig. 1).
Feed consumption (Fig. 2) in all groups was similar to
controls forthe entire study except for a slight decrease
during the first 2 weeks in the high dose group (15
mmole/kg EGPE). In contrast, a dose-dependent de-
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FIGURE 1. Meanbodyweight ofmaleratsexposed to EGPE (6-week
gavage study): (0) 15; (A) 7.5; (+) 3.75; (U) 1.88 mmole/kg; (0)
controls. An asterisk indicates that values are significantly differ-
ent from controls (p < 0.05).
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crease in body weight gain (Fig. 3) and feed consump-
tion (Fig. 4) was seen in animals exposed to EGPEA. In
addition, an initial weight loss during the first week
only, was seen in the two surviving animals exposed to
30 mmole/kg EGPEA.
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FIGURE 3. Mean body weight of male rats exposed to EGPEA
(6-weekgavagestudy): (0)30; (0) 15; (A) 7.5mmole/kg; (D) con-
trols. An asterisk indicates that values are significantly different
from controls (p S 0.05).
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FIGURE 2. Feed consumption ofmale ratsexposedto EGPE (6-week
gavage study): (0) 15; (A) 7.5; (+) 3.75; (U) 1.88 mmole/kg; (O)
controls. An asterisk indicates that values are significantly differ-
ent from controls (p s 0.05).
FIGURE 4. Feed consumption of male rats exposed to EGPEA
(6-week gavage study): (0) 30; (0) 15; (A) 7.5 mmole/kg; (E) con-
trols. An asterisk indicates that values are significantly different
from controls (p s 0.05).
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Table 4. Hemoglobinuria following administration of EGPE
and EGPEA: 6-week gavage study.a
30 15 7.5 3.75 1.88
mmole/kg mmole/kg mmole/kg mmole/kg mmole/kg
EGPE b 10/10 10/10 10/10 2/10
EGPEA 10/10 10/10 10/10
'Observed on dropping trays. All dose groups were affected but
number of animals involved and severity of response decreased as
study progressed.
bStudy not conducted at these doses.
Red discolored urine diagnosed as hemoglobinuria
(Ames N-Multistix-C reagent strip) was seen on drop-
ping trays in all groups exposed to EGPE and EGPEA
(Thble 4). The number of animals involved and the
frequency of the observation decreased as the study
progressed. Other clinical signs seen in some but n6t all
rats administered the high and intermediate doses of
EGPE included weakness, labored breathing, prostra-
tion, and rales, and at the high dose of EGPEA,
narcosis and sialorrhea.
Both compounds produced effects on red blood cells
(Fig. 5). Significant dose-dependent decreases in hemo-
globin concentration, hematocrit (except the EGPE
groups) and red blood cell counts were seen in survivors
at all dose levels at termination. Additional blood
changes which reflected toxic effects were increases in
platelet count, nucleated red blood cells, anisocytosis,
macrocytosis and poly- and hypochromasia. White blood
cell counts were normal in all groups exposed to EGPE,
while a dose-dependent increase in white blood cell
counts was observed in animals exposed to 7.5 and 15
mmole/kg EGPEA. The increase was statistically
significant in the high dose group only. Differential
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FIGURE 5. Comparative hematology ofmale rats exposed to EGPE
and EGPEA (6-week gavage study). Bars indicate percent of
control values: lightbars, normalvariation; darkbars, significantly
different from controls (p S 0.05).
white blood cell counts were normal at all dose levels of
both compounds.
EGPE and EGPEA produced no compound-related
effects on clinical chemistries examined. Changes ob-
served were, at most, slight, not dose related and
reflected spurious changes frequently observed in this
species.
Only the high dose (15 mmole/kg) ofEGPE produced
a slight, but significant, reduction of terminal body
weight while both 15 and 7.5 mmole/kg EGPEA groups
had a significantly reduced terminal body weight. A
dose dependent increase in absolute and relative spleen
weights was observed among all groups exposed to
either compound (Fig. 6). The increases in absolute
weights were statistically significant at the 15 and 7.5
mmole doses of EGPE and the relative spleen weights
were significant at all doses except 1.88 mmole/kg
EGPE. A reduction in absolute testicular weight but
not in relative weight was seen in animals exposed to 15
mmole/kg EGPEA. The testes weights of the 7.5
mmole/kg EGPEA rats and all groups of EGPE were
normal. All other organ weights were normal or
reflected decreased body weight gain.
Gross pathologic examination of the 30 mmole/kg
EGPEA animals that died or were killed after two or
three doses revealed serous atrophy ofthe bone marrow
(4/8), minimal to moderate hemorrhage in the
nonglandular portion of the stomach (8/8), and some
discoloration of the liver and kidneys (4/8).
Histologic examination of tissues collected from the
eight rats that died or were killed after two or three
doses of 30 mmole/kg EGPEA revealed minor
cytoplasmic vacuolation (3/8) and minor to moderate
degeneration of the seminiferous tubules in the testes
(4/8). Degenerated sperm cells were seen in the lumen
ofthe epididymides ofsix ofthese eight rats. Additional
compound-related changes included cortical (6/8) and
medullary necrosis (4/8) and cortical atrophy of the
thymus and hepatocyte hypertrophy (4/8), eosinophilic
cytoplasmic changes (1/8), hydropic degeneration (3/8),
and sinusoidal collapse (1/8) in the liver. Kidney changes
FIGURE 6. Comparative absolute and relative spleen and( testes
weights of rats exposed to EGPE and EGPEA (6-week gavage
study). Bars indicate percent of control values: light bars, normal
variation; dark bars, significantly different from controls (p
0.05).
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consisted of hyalin droplet degeneration (1/8) in the
ascending limb of Henle's loop. Glomerular effusions
(5/8) were also present. Splenic changes included lym-
phoid hypoplasia (2/8) and red pulp atrophy (5/8), while
karyopyknosis (4/8) was seen in the mesenteric lymph
nodes.
Gross pathologic findings for the remaining groups
exposed to EGPEA and the groups exposed to EGPE
are compared in Table 5. Splenic enlargement was seen
in rats exposed to 15, 7.5 and 3.75 mmole/kg EGPE and
15 and 7.5 mmole/kg EGPEA. Testicular atrophy was
seen in one rat and minimal hemorrhage in the
nonglandular portion of the stomach in another rat
exposed to 15 mmole/kg EGPEA.
Histologic lesions are compared in Table 6. EGPE
produced congestion and extramedullary hematopoiesis
of the spleen in animals exposed to 15, 7.5 and 3.75
mmole/kg. Renal effects included proteinaceous casts
(15 mmole/kg only) and hemosiderin in the proximal
convoluted tubules at all dose levels. Liver effects were
focal hemosiderin in the 15 mmole/kg dose group.
Testicular changes seen in the 15 mmole/kg EGPEA
group included cytoplasmic vacuolation in the seminifer-
ous tubules and degenerated sperm in the lumen ofthe
epididymides of one animal, while another rat had
atrophy of the seminiferous tubules. A minimal to
moderate incidence of brown pigment was seen in the
proximal convoluted tubules of 9/10 rats. The only
possible treatment-related change seen in the low dose
group (7.5 mmole/kg EGPEA) was brown pigment in
the convoluted tubules of eight of ten of the animals.
Two-Week Inhalation Studies. Mean analytic con-
centrations and standard deviations were 786 + 91, 406
+ 24, 206 + 13, 103 + 10 and 0.0 ppm for EGPE and 825
+ 34, 389 + 14, 203 + 5, 92 ± 6 and 0.0 ppm for
EGPEA. These compared favorably with target concen-
trations of 800, 400, 200, and 100 ppm.
Body weight changes are shown in Figures 7 and 8 for
animals exposed to EGPE and Figures 9 and 10 for
animals exposed to EGPEA. Body weight gains were
comparable to control values for all groups of both
compounds. A weight loss, seen on day 10 in the 100
ppm EGPE group, resulted from a malfunction in an
automatic water system.
Hemoglobinuria (Table 7) confirmed by Ames
N-Multistix-C reagent strips was observed on dropping
trays beneath 2/5 males and 3/5 females exposed to 800
ppm EGPE and 1/5 males exposed to 400 ppm EGPE.
Hemoglobinuria was observed in 4/5 males and 5/5
females exposed to 800 ppm EGPEA, 4/5 females
exposed to 400 ppm EGPEA and 1/5 females exposed to
200 ppm EGPEA. Urine discoloration resolved in all
animals after 2 days and did not reappear following
subsequent exposures.
Hemoglobin concentration, hematocrit, red blood cell
counts, and red blood cell indices (mean corpuscular
volume, MCV; mean corpuscular hemoglobin, MCH;
mean corpuscular hemoglobin concentration, MCHC)
following exposure to EGPE and EGPEA are compared
in Figures 11 and 12. In males, except for a slight but
significant decrease in red blood cell counts following
exposure to 800 ppm EGPE and EGPEA hemoglobin
concentration, hematocrit and red blood cell counts
were normal. Slight but significant increases were
observed in MCV at 800 and 400 ppm EGPE and
EGPEA, and in MCH at 800 and 400 ppm EGPE and
800 ppm EGPEA. MCHC values were comparable to
controls.
ITable 5. Comparative gross pathology following exposure to EGPE and EGPEA: 6-week gavage study.
Compound Site Lesion 15 mmole/kg 7.5 mmole/kg 3.75 mmole/kg 1.88 mmole/kg
EGPE Spleen Enlarged, dark 4a 5 1 0
EGPEA Spleen Enlarged 7 3 b
Testes Atrophy 1 0 - -
aNumber of male rats responding with lesion: N = 10.
bStudy not conducted at these doses.
Table 6. Comparative histopathology following exposure to EGPE and EGPEA: 6-week gavage study.
Compound Site Lesiona 15 mmole/kg 7.5 mmole/kg 3.75 mmole/kg 1.88 mmole/kg
EGPE Spleen Congestion 61) 5 10 0
Extramedullary hematopoiesis 0 4 3 0
Liver Focal hemosiderin 3 0 0 0
Kidney Proteinaceous casts 8 0 0 0
Hemosiderin 8 8 2 2
EGPEA Spleen Congestion 2 0 -
Kidney Brown pigment 9 8
Testes Atrophy or cytoplasmic vacuolizationi
of seminiferous tubules 2 0O
Epididymides Degenerated sperm in lumen 1 0
aNone of these lesions were seen in control animals.
bNumber of male rats responding with lesions: N = 10.
cStudy not conducted at these doses.
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FIGURE 7. Mean body weights of male rats exposed to EGPE
(2-week inhalation study): (U)800; (+)400; (A)200; (0) 100ppm;
(O) controls.
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FIGURE 8. Mean body weights of female rats exposed to EGPE
(2-week inhalation study): (U) 800; (+) 400; (A) 200; (0) 100 ppm;
(E) controls.
Only the red blood cell count was slightly but
significantly decreased in females exposed to 800 ppm
EGPE, while hemoglobin concentration, hematocrit,
and red blood cell counts were decreased slightly in
females exposed to 800 and 400 ppm EGPEA. MCV and
MCH were significantly increased in females exposed to
800 and 400 ppm EGPE and 800 ppm EGPEA. MCHC
was comparable to controls.
Reticulocytes were increased in both sexes after
exposure to 400 ppm EGPE. Absolute and relative
white blood cell counts and platelet counts were compa-
rable to control values at all exposure levels for both
compounds. Changes in red blood cell morphology
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FIGURE 9. Mean body weights of male rats exposed to EGPEA
(2-weekinhalation study): (U) 800; (+)400; (A)200; (0) 100ppm;
([) controls.
6 8
DAY OF EXPERIMENT
FIGURE 10. Mean body weights of female rats exposed to EGPEA
(2-week inhalation study): (U)800; (+)400; (A)200; (0) 100ppm;
(LO) controls.
observed at 800 and 400 ppm EGPE and EGPEA
included increased polychromasia, anisocytosis, macro-
cytosis, microcytosis, stomatocytes, hypochromasia and
Howell-Jolly Bodies. The number of animals showing
these changes, as well as the severity ofchanges, were
concentration dependent and considered significant at
800 and 400 ppm for both sexes and both compounds.
No hematological signs of toxicity were seen in males
and females exposed to 200 or 100 ppm EGPE and
EGPEA.
Clinical chemistries (aspartate aminotransferase, ala-
nine aminotransferase, alkaline phosphatase, urea
nitrogen, creatinine, and sorbital dehydrogenase) were
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Table 7. Hemoglobinuria following exposure to EGPE and
EGPEA: 2-week inhalation study.a
800 ppm 400 ppm 200 ppm 100 ppm
5Mb 5Fb 5M 5F 5M 5F 5M 5F
EGPE 2 2 1 0 0 0 0 0
EGPEA 4 5 0 4 0 1 0 0
aObserved on dropping trays. All signs resolved after second-
third exposure.
bNumber of rats examined.
normal in both sexes at all concentrations in animals
exposed to EGPE. An increase in lactate dehydroge-
nase (100 ppm) and a decrease in glucose (100 and 800
ppm) in females were considered spurious and not
toxicologically significant.
Clinical chemistry changes were seen in males only
exposed to EGPEA and included a slight but significant
decreaseinserumureanitrogenandalanineaminotrans-
ferase at 800 ppm and alanine aminotransferase at 200
and 100 ppm. None of these changes were of a magni-
tude to represent an untoward biologic effect and may
represent spurious excursions frequently seen in the
rat. All other clinical chemistries (aspartate amino-
transferase, lacticdehydrogenase, alkalinephosphatase,
glucose and treatinine) were normal.
Terminal body weights of all animals exposed to
either compound were comparable to control values.
Absolute and relative (to body weight) spleen weights
(Fig. 13) were significantly increased in males and
females exposed to 800 ppm EGPE and EGPEA and in
males only at 400ppm EGPEA. Relative spleenweights
were also increased in males and females exposed to 400
ppm EGPE and EGPEA. No significant differences
were seen in spleen weights of animals exposed to 200
and 100 ppm of either compound.
Absolute and relative (to body weight) liver, kidney,
brain, heart and gonad weights of both sexes were
normal at all exposure levels of EGPE.
Absolute and relative liver weights were increased
slightly in females exposed to 800 and 100 ppm EGPEA
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FIGURE 11. Comparative hematology ofmale rats exposed to EGPE
and EGPEA (2-week inhalation study). Bars indicate percent of
controlvalues: lightbars, normal variation; darkbars, significantly
different from controls (p S 0.05).
FIGURE 12. Comparative hematology of female rats exposed to
EGPE and EGPEA (2-week inhalation study): bars indicate
percent of control values; light bars: normal variation; dark bars:
significantly different from controls (p S 0.05).
Table 8. Comparative gross and histopathology following exposure of rats to EGPE and EGPEA: 2-week inhalation study.
800 ppm 400 ppm 200 ppm 100 ppm
SMW 5F 5M 5F 5M 5F 5M 6F
EPGE
Gross examination
Dark spleens 2 0 0 0 0 0 0 0
Histologic examination
Spleen congestion 3 4 2 2 0 0 0 0
Lymphoid hyperplasia 1 1 1 1 0 0 0 0
Extramedullary hematopoiesis 2 0 1 0 0 0 0 0
Hemosiderin 2 2 0 2 0 0 0 0
EGPEA
Gross examination
Abnormalities 0 0 0 0 0 0 0 0
Histologic examination
Spleen: extramedullary hematopoiesis 5 5 0 0 0 0 0 0
Kidney: extramedullary hematopoiesis 0 5 0 0 0 0 0 0
Liver: hemosiderin 0 4 0 0 0 0 0 0
aNumber of rats examined.
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FIGURE 13. Comparative absolute and relative spleen weights of
male and female rats exposed to EGPE and EGPEA (2-week
inhalation study). Bars indicate percent of control values: light
bars, normal variation; dark bars, significantly different from
controls (p S 0.05).
and a slight increase in relative liver weight was seen in
females exposed to 400 ppm. The increases were very
slight and not considered biologically significant. Abso-
lute and relative liver weights of males at all exposure
concentrations were comparable to control values. All
other absolute and relative organ weights (kidneys,
brain, heart, gonads) were normal at all exposure
concentrations in both sexes.
On gross examination (Table 8), the spleens oftwo of
five male rats exposed to 800 ppm EGPE were dark and
granular. Nocompound-related grosspathologic changes
were observed in any of the other rats exposed to
EGPE or in animals of either sex exposed to EGPEA.
Compound-related histopathologic changes (Table 8)
seen in the spleens of both sexes exposed to 800 or 400
ppm EGPE included minor splenic congestion, lym-
phoid hyperplasia, extramedullary hematopoiesis, and
hemosiderin. No other compound-related effects were
observed in these animals or in either males or females
exposed to 200 or 100 ppm of EGPE.
Histologic changes were seen in males and females
exposed to 800 ppm EGPEA only. Males (5/5) had minor
to moderate extramedullary hematopoiesis of the
spleen. Females had minor pigmentation in the proxi-
mal convoluted tubules (5/5) of the kidneys, minimal to
minor extramedullary hematopoiesis (5/5) ofthe spleen,
and minimal to moderate hemosiderosis of the Kupffer
cells (4/5) in the liver.
Discussion
EGPE and EGPEA exhibit a relatively low degree of
acute toxicity following exposure by oral, inhalation,
dermal and ocular administration. The primary site of
systemic toxicity in rats appears to be the red blood cell
with clinical evidence ofhemoglobinuria following single
doses of high concentrations orally and by inhalation.
These findings are comparable to those of single-dose
studies reported in the literature for EGPE (1,11).
Bloody urine is also associated with exposure to the
lower molecular weight derivatives ofglycol ethers such
as EGME, EGEE and EGEEA (1). EGPEA appears
slightly less toxic acutely than EGPE.
Repeated exposures to EGPE or EGPEA either
orally or by inhalation appear to produce similar re-
sponses in rats. The primary site of toxic action is the
red blood cell with secondary effects seen in the liver,
spleen and kidneys.
Orally, EGPEA (15 mmole/kg/day) produced testicu-
lar injury in two rats. No testicular changes were seen
following oral administration of an equimolar dose of
EGPE. Testicular injury has been reported for the
lower molecular weight ethylene glycol derivatives
EGME and EGEE and their esters, EGMEA and
EGEEA, when administered by gavage (62.5-4000
mg/kg) to mice over a 5-week period (12). Leukopenia,
which was also seen in this study (12) was not seen in
the present study with EGPE and EGPEA.
Testicular injury has been reported also following
repeated inhalation exposures to EGME in rats (1000
and 300 ppm, 6 hr/day) over a 2-week period (13). No
testicular injury was seen following 2-week vapor expo-
sures with as high as 800 ppm EGPE and EGPEA.
Hematologic changes associated with the red blood cell
population following EGPE and EGPEA vapor expo-
sure are similar to those described in the literature
following vapor exposure to EGME, EGMEA, EGEE
and EGEEA. Whiteblood cellandbone marrowchanges
were not observed in the present study.
Table 9 presents theno-observed effect levels (NOEL)
for the various parameters studied in animals exposed
to EGPE or EGPEA by the oral and inhalation routes.
In general, when EGPE and EGPEA have toxicologic
effects similar to those described in the literature for
Table 9. Comparative "no-observed effect level" (NOEL) following oral and inhalation exposure to EGPE and EGPEA.
EGPE EGPEA
Gavage, Inhalation, Gavage, Inhalation,
mmole/kg ppm mmole/kg ppm
Body weight 7.5 800 7.5 800
Clinical signs < 1.88 200 < 7.5 100
Hematology < 1.88 200 < 7.5 200
Clinical chemistry 15 800 15 800
Gross examination < 1.88 200 < 7.5 200
Microscopic examination < 1.88 200 < 7.5 400
Overall NOEL < 1.88 200 < 7.5 100
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EGME, EGMEA, EGEE, and EGEEA, on a relative
basis (equimolar) EGPE and EGPEA are less potent
than their lower molecular weight homologs.
Conclusion
EGPE and EGPEA exhibit a relatively low degree of
acute toxicity following exposure of animals by oral,
inhalation, dermal and ocular administration. The pri-
mary site of systemic toxicity after single-dose oral or
inhalation exposure is the red blood cell.
The primary site of toxicity following oral exposure
for 6 weeks or inhalation exposure for 2 weeks is the red
blood cell with secondary changes produced in the liver,
spleen and kidneys. Extremely high oral doses of
EGPEA, but not an equimolar dose of EGPE, causes
testicular injury. Inhalation exposure to concentrations
as high as 800 ppm EGPE or EGPEA for 2 weeks does
not produce testicular damage.
Although there are striking similarities between the
toxicity of EGPE and EGPEA, they are less toxic on a
relative basis (equimolar) than the lower molecular
weight ethylene glycol derivatives EGME, EGMEA,
EGEE and EGEEA.
The authors wish to express thanks to the personnel of the
Toxicology and Clinical Chemistry Sections of the Health and
Environment Laboratories, Eastman Kodak Company, Rochester,
NY, for their valuable assistance.
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